Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Myopia, Degenerative

• Effect of Atropine on Pupil Size and Quality of Vision
• Efficacy of IVMED-85 on Pediatric Myopia
• MAD Trial: Myopia Atropine Dose
• Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents
• Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
• Study of OT-101 in Treating Myopia
• Low-dose AtropIne for Myopia Control in Children
• Atropine 0.01% Eye Drops in Myopia Study
• Eye Drops Study for Myopia Control in Schoolchildren
• Ocular Discomfort Assessment After Intravitreal Injections
• Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
• A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV
• Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
• Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
• Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen
• Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
• Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)